The invention described herein relates generally to an imaging device, in particular, an imaging means for enhancing visualization of veins, arteries and other subcutaneous structures of the body for facilitating fluid insertion into or extraction from the body or otherwise visualizing subcutaneous structures for diagnosis of the medical condition of a patient or administration of medical treatment to a patient.
A visit to a doctor's office, a clinic or a hospital may necessitate vascular access that is, the insertion of a needle or catheter into a patient's vein or artery. These procedures may be required for the following reasons: to administer fluids, drugs or solutions, to obtain and monitor vital signs, to place long-term access devices, and to perform simple venipunctures. Vascular access ranks as the most commonly performed invasive, medical procedure in the U.S—over 1.4 billion procedures annually—as well as the top patient complaint among clinical procedures. The overwhelming majority of vascular access procedures is performed without the aid of any visualization device and relies on what is observed through the patient's skin and by the clinician's ability to feel the vessel. Medical literature reports the following statistics: 28% first attempt TV failure rate in normal adults, 44% first attempt IV failure in pediatrics, 43% of pediatric IVs require three or more insertion attempts, 23% to 28% incidence of extravasations/infiltration, 12% outright failure rate in cancer patients, 25% of hospital in-patients beyond three days encounter difficult access.
It is known in the art to use an apparatus to enhance the visual appearance of the veins in a patient to facilitate insertion of needles into the veins. An example of such a system is described in U.S. Pat. Nos. 5,969,754 and 6,556,858 incorporated herein by reference as well as a publication entitled “The Clinical Evaluation of Vein Contrast Enhancement”. Luminetx is currently marketing such a device under the name “Veinviewer Imaging System” and information related thereto is available on its website, which is incorporated herein by reference.
The Luminetx Vein Contrast Enhancer (hereinafter referred to as LVCE) utilizes an infrared light source for flooding the region to be enhanced with infrared light generated by an array of LEDs. A CCD imager is then used to capture an image of the infrared light reflected off the patient. The resulting captured image is then projected by a visible light projector onto the patient in a position closely aligned with the image capture system. Given that the CCD imager and the image projector are both two dimensional, and do not occupy the same point in space, it is relatively difficult to design and build a system that closely aligns the captured image and the projected image.
A further characteristic of the LVCE is that both the imaging CCD and the projector have fixed focal lengths. Accordingly, the patient must be at a relatively fixed distance relative to the LVCE. This necessitates that the LVCE be positioned at a fixed distance from the region of the patient to be enhanced.
The combination of the size of the LVCE and the fixed focal arrangement precludes using the LVCE as small portable units that are hand held:
Other patents such as U.S. Pat. No. 6,230,046, issued to Crane et al. assigned to The United States of America as represented by the Secretary of the Air Force, implement a light source for illuminating or transilluminating the corresponding portion of the body with light of selected wavelengths and a low-level light detector such as an image intensifier tube (including night vision goggles), a photomultiplier tube, photodiode or charge coupled device, for generating an image of the illuminated body portion, and optical filter(s) of selected spectral transmittance which can be located at the light source(s), detector, or both.
All citied references are incorporated herein by reference in their entireties. Citation of any reference is not an admission regarding any determination as to its availability as prior art to the claimed invention.
Finding a vein, necessary for administering intravenous solutions, drips and the like, can often be difficult. During venous penetration, whether for an injection or drip, it is essential to stick a vein in exactly the right location. If a practitioner is only slightly off center, the needle will more then likely just roll off.
The present invention is a Miniature Vein Enhancer that includes a Miniature Projection Head. The Miniature Projection Head of the present invention implements a polarized laser light. This diminishes the effects of specular reflection off the surface of the skin. The Veinviewer Imaging System, produced by Luminetx, uses a polarized filter to polarize the LED light. This polarized LED light is then rotated 90° in front of the camera, thus causing increased power loss.
In addition, the IR and visible lasers in the present invention can be modulated to allow a regular photodiode to detect the different signals from each wavelength separately. Furthermore, the IR laser power of the present invention is dynamically altered during each scan line, thus increasing the working range of the photodiode, and allowing for constant DC gain.
One key feature of the present invention, not present in the prior art, is the use of a hot mirror. A brief description now follows. First, a hot mirror is a specialized dielectric mirror, a dichromatic interference filter often employed to protect optical systems by reflecting heat back into the light source. In addition, hot mirrors can be designed to be inserted into at optical system at an incidence angle varying between zero and 45 degrees. Hot mirrors are useful in a variety of applications where heat build-up can damage components or adversely affect spectral characteristics of the illumination source. These characteristics, although useful in some applications, are not particularly important within the context of the present invention. Generally, wavelengths reflected by an infrared hot mirror range from about 750 to 1250 nanometers. By transmitting visible light wavelengths while reflecting infrared, hot mirrors can also serve as dichromatic beam splitters for specialized applications in fluorescence microscopy, as in the present invention. As mentioned above, hot mirrors are mirrors that may be coated with a Dichroic material, or the like. A Dichroic material is either one which causes visible light to be split up into distinct beams of different wavelengths, or one which light rays having different polarizations are absorbed by different amounts, the former is implemented in the present invention.
The present invention also improves on the Crane Patent. In Crane, the vein enhancer implements two separate devices, one for illumination and/or transillumination and a separate device used for detecting the low light. Such a configuration is awkward and difficult to operate. In addition, having two separate devices increases the likelihood losing one of them.
The present invention can implement multiple photo detectors spatially separated so as to increase sensitivity, reduce speckle, and reduce specular reflection. However, as mentioned previously, one can achieve a reasonable result by using a single PD, this will depend on the desired output and/or operating needs.
The scanning method implemented with the present invention is unique. In general, the lower level of precision required, the easier it is to produce the pattern. In the present invention (the embodiment without image memory), as opposed to a traditional laser projectors known in the art, there is no need for a reproducible scan pattern, that is, from frame to frame the laser scan lines do not need to fall reproducibly upon the scan lines of the prior frame, thus, there is no need to know the instantaneous position of the laser. The reason being, the visible light of the present invention is coaxially aligned to the 740 un laser. The visible light is a function of the received image in real time. Accordingly, whatever location is being imaged is instantaneously being projected.
The present invention also implements a scanner. The scanner of the present invention can include an amplitude modulated circular mirror. In this case a mirror is arranged to run at resonance in a circular or oval pattern. The magnitude of the circle is then amplitude modulated at a rate in excess of 30 Hz (to avoid appearance of flicker). Accordingly, a scan pattern is formed which starts with small concentric circles and grows sequentially larger, until reaching a limit and than collapsing sequentially to the smallest circle. Some advantages of this configuration include: circle and oval scan; mirror and laser spot always moving, hence, no down time; center of image naturally brighter; scan lines per inch can be denser in center; calibration line is outside circle (can be clipped by housing); and operation at resonance means low power.
The miniature vein enhancer of the present invention may be used by a practitioner to locate a vein, particularly useful when trying to locate a vein in the very old or very young. More then fifty percent of attempts to find a vein, in old people, who have a generally high percentage of loose, fatty tissue, and children, who have a generally high percentage of small veins and “puppy fat”, are unsuccessful. The present invention is aimed at reducing and/or preventing the discomfort and delay associated with botched attempts to pierce veins for injections and blood tests. In addition, the present invention can cut the time it takes to set up potentially life-saving intravenous drip.
It is an object of the present invention to make a Miniature Vein Enhancer that is cost effective to manufacture.
It is another object of the present invention to make a Miniature Vein Enhancer that will allow a practitioner pinpoint a vein for intravenous drip, blood tests, and the like.
It is still another object of the present invention to make a Miniature Vein Enhancer that will reduce and/or diminish the amount of botched attempts to pierce a vein.
It is still a further object of the present invention to make a Miniature Vein Enhancer that is easy to operate.
It is another object of the present invention to make a Miniature Vein Enhancer that may be disposed of after use.
It is yet another object of the present invention to make a Miniature Vein Enhancer that may be hand held.
It is still another object of the invention to make a Miniature Vein Enhancer that implements a Miniature Projection Head in Alternating frame mode.
It is yet another object of the present invention to make a Miniature Vein Enhancer that implements a Miniature Projection Head that operates in Dual Buffer Mode.
It is yet another object of the present invention to make a Miniature Vein Enhancer that implements a Miniature Projection Head that operates in Real Time Mode.
As required, detailed embodiments of the present invention are disclosed herein; however, it is to be understood that the disclosed embodiments are merely exemplary of the invention, which may be embodied in various forms. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present invention in virtually any appropriately detailed structure.
A detailed description of the different configurations of lasers, mirrors, diodes, gain control systems, as well as the different power controls located inside the MPH will now be discussed. A detailed description of the MPH will then follow.
The present invention can be arranged as either a binary system or grayscale system. In a grayscale system, the 740 nm signal received by the PD is simply echoed and re-transmitted by the visible 638 nm laser 201. In this manner, various levels of intensity can be shown. Accordingly, the image of a vein may vary in intensity as a function of the magnitude of signal received. In a binary system, the projected image is either on or off. To determine whether the projected image should be on or off, a comparator with a trip point is placed after the photodiode. If the signal crosses the trip point the output laser 638 nm 201 is turned on and vice versa. There are several ways to set the trip point. For example, a user dial or press button (or any other input means) could be placed on the device, and the user can manually adjust the trip point (essentially making the device more or less sensitive).
The vein enhancer of the present invention, implements at least two lasers, 201 and 202, contained in the same housing, as seen in
Laser projection devices have agency regulations dictating power output limitations. Generally, the power of a laser is limited to a threshold level so as to protect the user's eye from injury. If, however, the user's eye is prevented from getting too close to the laser, then the power of the laser may be increased. Prior art in the past have implemented physical barriers that are incorporated into the design of the laser. These barriers help prevent the user's eye from getting too close to the origin of the laser projections, thus laser power may be increased. For example, previous prior art have used protruding bars (similar to those used in football helmets) that are placed in the direction of the optical path. This prevents the user from placing an eye too close to the laser.
In the present invention, signal processing can be utilized to control the power output. For example, in one embodiment the acquired image pattern is stored in a computer memory. The image is then processed to determine whether veins are present, and only upon confirmation of the vein being present is the image projected. In this manner, the visible laser will not be turned on if the laser is in the direction of the user.
In another embodiment, the power of the 740 nm laser 202 can be set to an initially low setting. Once the laser detects a vein, the power of the 740 nm laser 202 can be increased and the 638 nm laser 201 turned on.
In yet another embodiment, the laser can be configured so that the laser will only be activated when a proximity sensor 220 determines the surface, or eye of a user. The interface of proximity sensor 220 and the main electronics 260 may be seen in
Although the vein enhancer of the present invention may be configured to operate in a multitude of ways, it includes at least one laser, one photo diode and at least one mirror. Depending on the desired output and/or operating costs additional components may be incorporated into the design of the present invention. Two embodiments that have been found useful in the vein enhancement art will now be discussed, a discussion of alternative embodiments will follow.
Both embodiments implement 2 photo diodes (hereinafter PDs) and at least two lasers. In addition, depending on the desired result, there can be a polarization film 270, as seen in
Regarding the first embodiment, it is necessary to co-axially align the two lasers. Co-axially aligning the two lasers can be achieved in a multitude of ways. Two methods that have proven to be effective include implementing, either, a dielectric mirror or a polarizer.
The first configuration includes a first laser calibrated to transmit light in the Infrared (hereinafter IF) spectrum, that is 740 nm, and a second laser calibrated to transmit a light in the red color spectrum, that is ≈638 nm. The first configuration, as mentioned above, implements a hot mirror 204 coated with a Dichroic substance, which separates and directs the light onto two separate diodes. This system allows the visible and IR laser reflections in real-time without the use of a memory chip. With this embodiment the 638 nm laser 201 is oriented behind the dielectric mirror. The dielectric mirror is selected so that the 638 nm laser light passed through but the 740 nm is reflected. The 740 nm laser is aimed at the front of the dielectric mirror and is angled and aimed so that the refection of the 740 nm laser is coaxial with the 638 nm laser passing through the dielectric.
In the second configuration, the 638 nm laser is polarized in a first orientation and is placed behind the polarized element. The polarized element is selected so that the first polarized orientation passes through, but the second polarized angle is reflected. The 740 nm is polarized to the second polarized angle and is aimed at the front of the polarized element and is angled and aimed so that the reflection of the 740 nm laser is coaxial with the 638 nm laser passing through the polarized element.
Regarding the second embodiment, the two lasers are multiplexed. It has been noted that the signal received by the 740 nm PD of the present invention is representative of both the veins and the surface topology of the patient. Put another way, the surface of the patient affects the reflected signal. This is not desirable, in that the area of interest is the veins of the patient and not the surface topology of the patient. Thus, by using a second PH for receiving the 630 nm reflected signal, the 630 nm signal (the topology) can be subtracted from the 740 nm signal (topology+veins) yielding a signal that is solely the veins (topology+veins−topology=veins). In this system the microprocessor 250 or state machine circuit, as seen in
Other configurations may include a Multi laser array and a LED. First, the Multi laser array will be discussed. In this embodiment a linear array of visible lasers and a linear array of IR lasers may replace the single visible laser and single IR laser. With this type of configuration, the linear array of visible lasers and linear array of IR lasers are reflected off a single mirror that oscillates. An advantage of this laser configuration is twofold. First, the mirrors being implemented are less complex. Second, the collection means of the reflected IR light can be obtained by a retro collective mirror. A retro collective mirror is a mirror that has a field of view that corresponds to the array of lasers and moves in concert with the movement of the array of lasers. A characteristic that makes the retro collective mirror ideal for this configuration is the improved signal to noise ratio (SNR).
Evident from the above disclosure, it may be desired to implement one PD 207, as can be seen in
In another embodiment the, 638 nm and 740 nm, lasers may be modulated oppositely. In this embodiment the PD will also be responsive to the, 638 nm and 740 nm, laser, but the lasers will be modulated in opposite directions. More specifically, both the lasers can be pulsed on and off at high rates without affecting the apparent quality of the image (638 nm projection), or the quality of the acquired image (the reflections of the 740 nm laser). By synchronizing the two lasers so that the modulation is in opposite directions (the 638 nm on and 740 nm off, followed by, 638 nm off and 740 nm on), the image acquisition circuits (PD and amplifiers, if implemented) can be arranged to ignore signals when the 638 nm laser is on. In this embodiment, the visible 638 nm laser does not interfere at all with the image acquisition apparatus.
All the aforementioned embodiments implemented either single or multiple lasers. It shall be disclosed now that in all aforementioned embodiments a tightly focused LED may replace the lasers. It should be mentioned that this embodiment has limited use in that the resulting projection will not be a collimated laser beam and it will diverge over distance. However, in those limited instances where the distance from the device to the surface is closely held, an appropriate focusing can be obtained.
The present invention also includes a means for gain control. Two possible methods of adjusting the gain of the system are possible. A prior art method of adjusting gain is to fix the 740 nm laser output and to adjust the gain of the photo detection circuitry so as to get an appropriate signal (not too low and not saturated). However, there is complexity in such an adjustment due to the speed requirements of the photo detector gain adjustment. An alternative approach, as in the present invention, is to fix the gain of the photo detection circuitry, as in prior art, but adjust the power output of the 740 nm laser so that an appropriate signal is outputted from the photo detection circuitry (once again not too low, but not saturated). It is much easier to design circuits that adjust the 740 nm lasers due to the extremely high modulation bandwidth of the lasers. For example, the 740 nm laser may be modulated as needed to prevent saturation of the photo detector circuitry. Alternatively, the amplitude of the 740 nm laser can be adjusted to provide appropriate signal out of the photo detection circuitry.
Throughout all the embodiments previously discussed, adjusting the power of either the 638 nm laser, or 740 nm laser, can be achieved by either adjusting the current to the lasers, or alternatively, modulating the lasers on and off at a rapid rate. Regarding modulation, depending upon the duty cycle (pulse-width-modulation), the average laser intensity will be changed. With respect to the visible 638 nm laser, the human eye will integrate the signal and, provided the frequency of the PWM is faster than the eye integration time, the laser will appear dimmer as the on cycle time decreases, and vice versa. The power of the 740 nm laser may be also be adjusted by PWM, this modulation will have the same effect upon the received signal as if the current was decreased to the laser.
The MPH will now be described.
A publication in Laser Focus World, December 2004, authored by Chris Wiklof, entitled “Display technology spawns laser camera”, herein incorporated by reference, describes the SLBC of
Drawing one's attention to
A first mode of operation which will be referred to hereinafter as an “Alternating Frame Mode” (AFM) may be seen in
A second mode of operation is shown in
The DBM mode is advantaged as compared to the AFM in that the visible laser is on every frame, and therefore is twice as bright. However, the AFM mode is advantaged in that it only requires a single memory buffer and therefore is more cost effective than the DBM mode.
A third mode of operation is illustrated in
Drawing one's attention now to
In the RTM of
The MPH 200 may also include two laser sources. A first laser source 201 having a wavelength in the visible light spectrum, preferably 632 nm, and a second laser 202 having a wavelength preferably 740 nm, that is IR. Lasers 201 and 202 may be any suitable lasers known in the art.
Combiner 203 may have at least one bounce mirror. In a preferred embodiment there can be two bounce mirrors, 203a and 203b. In the preferred embodiment combiner 203 may also include a dielectric coated mirror 204. Mirror 204 may be any suitable type of dielectric coated mirror known in the available art. In a preferred embodiment mirror 204 was coated with a material that reflects IR and transmits other wavelengths. As mentioned above, the embodiment as depicted in
In normal operation, the embodiment as depicted in
In another embodiment of the present invention there can be what is known in the art as a “hot mirror”. Mirror 206 is preferably coated with a dichroic coating. This acts as a beam splitter. In normal operation mirror 206 will direct the light onto two separate PDs. With this type of embodiment all other previously mentioned components may operate in the same manner. In normal operation laser 202 will transmit IR light 220 which will bounce off of bounce mirror 203a. At which time laser 202 will begin to transmit light 221 at 632 nm. Light 221 will pass through dielectric coated mirror 204 and light 220 will reflect of mirror 204, resulting in a beam of light 222 that is a combination of both lights, as seen in
Other embodiments may implement a MEMS scanner, as seen in
Furthermore, there can be any array of polarizing filters and/or infrared filters located between the collection mirror and the photodiode, as seen in
In the embodiments herein the visible light transmitted was a red laser. However, any visible color or combination of color could be transmitted. For example, three laser RGB could be utilized to transmit full color images onto the field of view.
While in the embodiments herein a single two-dimensional mirror which moves in two axis was used for steering the beam, other beam steering arrangements could be used. For example, the outgoing laser beams can be bounced first off a one dimensional high speed scanning mirror and then off a second lower speed mirror scanning in the opposite direction. There are many other methods known to those skilled in the art for creating raster and other scanned laser patterns.
While many of the embodiments described herein utilized vial holders with needles, there are many other medical procedures which need to view the veins. The invention is not intended to be limited to devices which attach to vial holders.
As various changes could be made in the above constructions without departing from the scope of the invention, it is intended that all matter contained in the above description shall be interpreted as illustrative and not in a limiting sense. In the view above it will be seen that several objects of the invention are achieved and other advantageous results attained, as defined by the scope of the following claims.
This application is a continuation of U.S. application Ser. No. 14/249,462, filed on Apr. 10, 2014, which is a continuation of Ser. No. 13/444,940, filed on Apr. 12, 2012, now issued as U.S. Pat. No. 8,750,970, which is a continuation of U.S. application Ser. No. 11/985,343, filed on Nov. 14, 2007, now issued as U.S. Pat. No. 8,255,040, which is a continuation in part of both: U.S. application Ser. No. 11/700,729, filed on Jan. 31, 2007, now issued as U.S. Pat. No. 8,838,210, which claims priority on U.S. Provisional Patent Application Ser. No. 60/817,623, filed Jun. 29, 2009; and also U.S. application Ser. No. 11/478,322, filed on Jun. 29, 2006, now issued as U.S. Pat. No. 8,478,386, which claims priority on U.S. Provisional Application Ser. No. 60/757,704, filed on Jan. 10, 2006, all disclosures of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3136310 | Meltzer | Jun 1964 | A |
3349762 | Kapany | Oct 1967 | A |
3511227 | Johnson | May 1970 | A |
3527932 | Thomas | Sep 1970 | A |
3818129 | Yamamoto | Jun 1974 | A |
3984629 | Gorog | Oct 1976 | A |
4030209 | Dreiding | Jun 1977 | A |
4057784 | Tafoya | Nov 1977 | A |
4109647 | Stern et al. | Aug 1978 | A |
4162405 | Chance et al. | Jul 1979 | A |
4182322 | Miller | Jan 1980 | A |
4185808 | Donohoe et al. | Jan 1980 | A |
4213678 | Pomerantzeff et al. | Jul 1980 | A |
4265227 | Ruge | May 1981 | A |
4312357 | Andersson et al. | Jan 1982 | A |
4315318 | Kato et al. | Feb 1982 | A |
4321930 | Jobsis et al. | Mar 1982 | A |
4393366 | Hill | Jul 1983 | A |
4495949 | Stoller | Jan 1985 | A |
4502075 | DeForest et al. | Feb 1985 | A |
4510938 | Jobsis et al. | Apr 1985 | A |
4536790 | Kruger et al. | Aug 1985 | A |
4565968 | Macovski | Jan 1986 | A |
4567896 | Barnea et al. | Feb 1986 | A |
4576175 | Epstein | Mar 1986 | A |
4590948 | Nilsson | Mar 1986 | A |
4586190 | Tsuji | Apr 1986 | A |
4596254 | Adrian et al. | Jun 1986 | A |
4619249 | Landry | Oct 1986 | A |
4669467 | Willett et al. | Jun 1987 | A |
4697147 | Moran et al. | Sep 1987 | A |
4699149 | Rice | Oct 1987 | A |
4703758 | Omura | Nov 1987 | A |
4766299 | Tierney et al. | Aug 1988 | A |
4771308 | Tejima et al. | Sep 1988 | A |
4780919 | Harrison | Nov 1988 | A |
4799103 | Muckerheide | Jan 1989 | A |
4817622 | Pennypacker et al. | Apr 1989 | A |
4846183 | Martin | Jul 1989 | A |
4861973 | Hellekson et al. | Aug 1989 | A |
4862894 | Fujii | Sep 1989 | A |
4899756 | Sonek | Feb 1990 | A |
4901019 | Wedeen | Feb 1990 | A |
4926867 | Kanda et al. | May 1990 | A |
RE33234 | Landry | Jun 1990 | E |
4938205 | Nudelman | Jul 1990 | A |
5074642 | Hicks | Dec 1991 | A |
5088493 | Giannini et al. | Feb 1992 | A |
5103497 | Hicks | Apr 1992 | A |
5146923 | Dhawan | Sep 1992 | A |
5174298 | Dolfi et al. | Dec 1992 | A |
5184188 | Bull et al. | Feb 1993 | A |
5214458 | Kanai | May 1993 | A |
5222495 | Clarke et al. | Jun 1993 | A |
5261581 | Harden, Sr. | Nov 1993 | A |
5293873 | Fang | Mar 1994 | A |
5339817 | Nilsson | Aug 1994 | A |
5371347 | Plesko | Dec 1994 | A |
5406070 | Edgar et al. | Apr 1995 | A |
5418546 | Nakagakiuchi et al. | May 1995 | A |
5423091 | Lange | Jun 1995 | A |
5436655 | Hiyama et al. | Jul 1995 | A |
5445157 | Adachi et al. | Aug 1995 | A |
D362910 | Creaghan | Oct 1995 | S |
5485530 | Lakowicz et al. | Jan 1996 | A |
5487740 | Sulek et al. | Jan 1996 | A |
5494032 | Robinson et al. | Feb 1996 | A |
5497769 | Gratton et al. | Mar 1996 | A |
5501680 | Kurtz | Mar 1996 | A |
5504316 | Bridgelall et al. | Apr 1996 | A |
5519208 | Esparza et al. | May 1996 | A |
5541820 | McLaughlin | Jul 1996 | A |
5542421 | Erdman | Aug 1996 | A |
5598842 | Ishihara et al. | Feb 1997 | A |
5603328 | Zucker et al. | Feb 1997 | A |
5608210 | Esparza et al. | Mar 1997 | A |
5610387 | Bard et al. | Mar 1997 | A |
5625458 | Alfano et al. | Apr 1997 | A |
5631976 | Bolle et al. | May 1997 | A |
5655530 | Messerschmidt | Aug 1997 | A |
5678555 | O'Connell | Oct 1997 | A |
5716796 | Bull et al. | Feb 1998 | A |
5719399 | Alfano et al. | Feb 1998 | A |
5740801 | Branson | Apr 1998 | A |
5747789 | Godik | May 1998 | A |
5756981 | Roustaei et al. | May 1998 | A |
5758650 | Miller et al. | Jun 1998 | A |
5772593 | Hakamata | Jun 1998 | A |
5787185 | Clayden | Jul 1998 | A |
5814040 | Nelson et al. | Sep 1998 | A |
5836877 | Zavislan | Nov 1998 | A |
5847394 | Alfano et al. | Dec 1998 | A |
5860967 | Zavislan et al. | Jan 1999 | A |
5929443 | Alfano et al. | Jul 1999 | A |
5946220 | Lemelson | Aug 1999 | A |
5947906 | Dawson, Jr. et al. | Sep 1999 | A |
5966204 | Abe | Oct 1999 | A |
5966230 | Swartz et al. | Oct 1999 | A |
5969754 | Zeman | Oct 1999 | A |
5982553 | Bloom et al. | Nov 1999 | A |
5988817 | Mizushima et al. | Nov 1999 | A |
5995856 | Mannheimer et al. | Nov 1999 | A |
5995866 | Lemelson | Nov 1999 | A |
6006126 | Cosman | Dec 1999 | A |
6032070 | Flock et al. | Feb 2000 | A |
6056692 | Schwartz | May 2000 | A |
6061583 | Ishihara et al. | May 2000 | A |
6083486 | Weissleder et al. | Jul 2000 | A |
6101036 | Bloom | Aug 2000 | A |
6113536 | Aboul-Hosn et al. | Sep 2000 | A |
6122042 | Wunderman et al. | Sep 2000 | A |
6132379 | Patacsil et al. | Oct 2000 | A |
6135599 | Fang | Oct 2000 | A |
6141985 | Cluzeau et al. | Nov 2000 | A |
6142650 | Brown et al. | Nov 2000 | A |
6149061 | Massieu et al. | Nov 2000 | A |
6149644 | Xie | Nov 2000 | A |
6171301 | Nelson et al. | Jan 2001 | B1 |
6178340 | Svetliza | Jan 2001 | B1 |
6179260 | Ohanian | Jan 2001 | B1 |
6230046 | Crane et al. | May 2001 | B1 |
6240309 | Yamashita et al. | May 2001 | B1 |
6251073 | Imran et al. | Jun 2001 | B1 |
6263227 | Boggett et al. | Jul 2001 | B1 |
6272376 | Marcu et al. | Aug 2001 | B1 |
6301375 | Choi | Oct 2001 | B1 |
6305804 | Rice et al. | Oct 2001 | B1 |
6314311 | Williams et al. | Nov 2001 | B1 |
6334850 | Amano et al. | Jan 2002 | B1 |
6353753 | Flock et al. | Mar 2002 | B1 |
6424858 | Williams | Jul 2002 | B1 |
6436655 | Bull et al. | Aug 2002 | B1 |
6438396 | Cook et al. | Aug 2002 | B1 |
6463309 | Ilia | Oct 2002 | B1 |
6464646 | Shalom et al. | Oct 2002 | B1 |
6523955 | Eberl et al. | Feb 2003 | B1 |
6542246 | Toida | Apr 2003 | B1 |
6556854 | Sato et al. | Apr 2003 | B1 |
6556858 | Zeman | Apr 2003 | B1 |
6599247 | Stetten | Jul 2003 | B1 |
6631286 | Pfeiffer et al. | Oct 2003 | B2 |
6648227 | Swartz et al. | Nov 2003 | B2 |
6650916 | Cook et al. | Nov 2003 | B2 |
6689075 | West | Feb 2004 | B2 |
6690964 | Bieger et al. | Feb 2004 | B2 |
6702749 | Paladin et al. | Mar 2004 | B2 |
6719257 | Greene et al. | Apr 2004 | B1 |
6755789 | Stringer et al. | Jun 2004 | B2 |
6777199 | Bull et al. | Aug 2004 | B2 |
6782161 | Barolet et al. | Aug 2004 | B2 |
6845190 | Smithwick et al. | Jan 2005 | B1 |
6882875 | Crowley | Apr 2005 | B1 |
6889075 | Marchitto et al. | May 2005 | B2 |
6913202 | Tsikos et al. | Jul 2005 | B2 |
6923762 | Creaghan, Jr. | Aug 2005 | B1 |
6980852 | Jersey-Willuhn et al. | Dec 2005 | B2 |
7092087 | Kumar et al. | Aug 2006 | B2 |
7113817 | Winchester, Jr. et al. | Sep 2006 | B1 |
7158660 | Gee, Jr. et al. | Jan 2007 | B2 |
7158859 | Wang et al. | Jan 2007 | B2 |
7204424 | Yavid et al. | Apr 2007 | B2 |
7225005 | Kaufman et al. | May 2007 | B2 |
7227611 | Hull et al. | Jun 2007 | B2 |
7239909 | Zeman | Jul 2007 | B2 |
7247832 | Webb | Jul 2007 | B2 |
7280860 | Ikeda et al. | Oct 2007 | B2 |
7283181 | Allen et al. | Oct 2007 | B2 |
7302174 | Tan et al. | Nov 2007 | B2 |
7333213 | Kempe | Feb 2008 | B2 |
D566283 | Brafford et al. | Apr 2008 | S |
7359531 | Endoh et al. | Apr 2008 | B2 |
7376456 | Marshik-Geurts et al. | May 2008 | B2 |
7428997 | Wiklof et al. | Sep 2008 | B2 |
7431695 | Creaghan | Oct 2008 | B1 |
7448995 | Wiklof et al. | Nov 2008 | B2 |
7532746 | Marcotte et al. | May 2009 | B2 |
7545837 | Oka | Jun 2009 | B2 |
7559895 | Stetten et al. | Jul 2009 | B2 |
7579592 | Kaushal | Aug 2009 | B2 |
7608057 | Woehr et al. | Oct 2009 | B2 |
7699776 | Walker et al. | Apr 2010 | B2 |
7708695 | Akkermans et al. | May 2010 | B2 |
7792334 | Cohen et al. | Sep 2010 | B2 |
7846103 | Cannon, Jr. et al. | Dec 2010 | B2 |
7848103 | Zhan | Dec 2010 | B2 |
7904138 | Goldman et al. | Mar 2011 | B2 |
7904139 | Chance | Mar 2011 | B2 |
7925332 | Crane et al. | Apr 2011 | B2 |
7966051 | Xie et al. | Jun 2011 | B2 |
8032205 | Mullani | Oct 2011 | B2 |
8078263 | Zeman et al. | Dec 2011 | B2 |
8187189 | Jung et al. | May 2012 | B2 |
8199189 | Kagenow et al. | Jun 2012 | B2 |
8320998 | Sato | Nov 2012 | B2 |
8336839 | Boccoleri et al. | Dec 2012 | B2 |
8364246 | Thierman | Jan 2013 | B2 |
8467855 | Yasui | Jun 2013 | B2 |
8480662 | Stolen et al. | Jul 2013 | B2 |
8494616 | Zeman | Jul 2013 | B2 |
8498694 | McGuire, Jr. et al. | Jul 2013 | B2 |
8509495 | Xu et al. | Aug 2013 | B2 |
8537203 | Seibel et al. | Sep 2013 | B2 |
8548572 | Crane | Oct 2013 | B2 |
8630465 | Wieringa et al. | Jan 2014 | B2 |
8649848 | Crane et al. | Feb 2014 | B2 |
20010006426 | Son et al. | Jul 2001 | A1 |
20010056237 | Cane et al. | Dec 2001 | A1 |
20020016533 | Marchitto | Feb 2002 | A1 |
20020118338 | Kohayakawa | Aug 2002 | A1 |
20020188203 | Smith et al. | Dec 2002 | A1 |
20030018271 | Kimble | Jan 2003 | A1 |
20030037375 | Riley et al. | Feb 2003 | A1 |
20030052105 | Nagano | Mar 2003 | A1 |
20030120154 | Sauer et al. | Jun 2003 | A1 |
20030125629 | Ustuner | Jul 2003 | A1 |
20030156260 | Putilin et al. | Aug 2003 | A1 |
20040015062 | Ntziachristos et al. | Jan 2004 | A1 |
20040015158 | Chen et al. | Jan 2004 | A1 |
20040022421 | Endoh et al. | Feb 2004 | A1 |
20040046031 | Knowles et al. | Mar 2004 | A1 |
20040171923 | Kalafut | Sep 2004 | A1 |
20040222301 | Willins et al. | Nov 2004 | A1 |
20040237051 | Clauson | Nov 2004 | A1 |
20050017924 | Utt et al. | Jan 2005 | A1 |
20050033145 | Graham et al. | Feb 2005 | A1 |
20050043596 | Chance | Feb 2005 | A1 |
20050047134 | Mueller et al. | Mar 2005 | A1 |
20050085732 | Sevick-Muraca et al. | Apr 2005 | A1 |
20050085802 | Gruzdev et al. | Apr 2005 | A1 |
20050113650 | Pacione et al. | May 2005 | A1 |
20050131291 | Floyd et al. | Jun 2005 | A1 |
20050135102 | Gardiner et al. | Jun 2005 | A1 |
20050141069 | Wood et al. | Jun 2005 | A1 |
20050143662 | Marchitto et al. | Jun 2005 | A1 |
20050146765 | Turner et al. | Jul 2005 | A1 |
20050154303 | Walker et al. | Jul 2005 | A1 |
20050157939 | Arsenault et al. | Jul 2005 | A1 |
20050161051 | Pankratov et al. | Jul 2005 | A1 |
20050168980 | Dryden et al. | Aug 2005 | A1 |
20050174777 | Cooper et al. | Aug 2005 | A1 |
20050175048 | Stern et al. | Aug 2005 | A1 |
20050187477 | Serov et al. | Aug 2005 | A1 |
20050215875 | Khou | Sep 2005 | A1 |
20050265586 | Rowe et al. | Dec 2005 | A1 |
20050281445 | Marcotte et al. | Dec 2005 | A1 |
20060007134 | Ting | Jan 2006 | A1 |
20060020212 | Xu et al. | Jan 2006 | A1 |
20060025679 | Viswanathan et al. | Feb 2006 | A1 |
20060052690 | Sirohey et al. | Mar 2006 | A1 |
20060081252 | Wood | Apr 2006 | A1 |
20060100523 | Ogle et al. | May 2006 | A1 |
20060103811 | May et al. | May 2006 | A1 |
20060122515 | Zeman et al. | Jun 2006 | A1 |
20060129037 | Kaufman et al. | Jun 2006 | A1 |
20060129038 | Zelenchuk et al. | Jun 2006 | A1 |
20060151449 | Warner, Jr. et al. | Jul 2006 | A1 |
20060173351 | Marcotte et al. | Aug 2006 | A1 |
20060184040 | Keller et al. | Aug 2006 | A1 |
20060206027 | Malone | Sep 2006 | A1 |
20060232660 | Nakajima et al. | Oct 2006 | A1 |
20060253010 | Brady et al. | Nov 2006 | A1 |
20060271028 | Altshuler et al. | Nov 2006 | A1 |
20060276712 | Stothers | Dec 2006 | A1 |
20070015980 | Numada et al. | Jan 2007 | A1 |
20070016079 | Freeman et al. | Jan 2007 | A1 |
20070070302 | Govorkov et al. | Mar 2007 | A1 |
20070115435 | Rosendaal | May 2007 | A1 |
20070129634 | Hickey et al. | Jun 2007 | A1 |
20070176851 | Willey et al. | Aug 2007 | A1 |
20070238957 | Yared | Oct 2007 | A1 |
20080045841 | Wood et al. | Feb 2008 | A1 |
20080147147 | Griffiths et al. | Jun 2008 | A1 |
20080194930 | Harris et al. | Aug 2008 | A1 |
20080214940 | Benaron | Sep 2008 | A1 |
20090018414 | Toofan | Jan 2009 | A1 |
20090082629 | Dotan | Mar 2009 | A1 |
20090171205 | Kharin et al. | Jul 2009 | A1 |
20100051808 | Zeman et al. | Mar 2010 | A1 |
20100061598 | Seo | Mar 2010 | A1 |
20100087787 | Woehr et al. | Apr 2010 | A1 |
20100177184 | Berryhill et al. | Jul 2010 | A1 |
20100312120 | Meier | Dec 2010 | A1 |
20110275932 | Leblond et al. | Nov 2011 | A1 |
20130147916 | Bennett et al. | Jun 2013 | A1 |
20140039309 | Harris et al. | Feb 2014 | A1 |
20140046291 | Harris et al. | Feb 2014 | A1 |
20140194747 | Kruglick | Jul 2014 | A1 |
Number | Date | Country |
---|---|---|
2289149 | May 1976 | FR |
1298707 | Dec 1972 | GB |
1507329 | Apr 1978 | GB |
S60-108043 | Jun 1985 | JP |
04-042944 | Feb 1992 | JP |
07-255847 | Oct 1995 | JP |
08-023501 | Jan 1996 | JP |
08-164123 | Jun 1996 | JP |
2000-316866 | Nov 2000 | JP |
2002-328428 | Nov 2002 | JP |
2002-345953 | Dec 2002 | JP |
2004-237051 | Aug 2004 | JP |
2004-329786 | Nov 2004 | JP |
2003-0020152 | Mar 2003 | KR |
WO 1994 22370 | Oct 1994 | WO |
WO 1996 39925 | Dec 1996 | WO |
WO 1998 26583 | Jun 1998 | WO |
WO 1999 48420 | Sep 1999 | WO |
WO 2001-82786 | Nov 2001 | WO |
WO 2003-009750 | Feb 2003 | WO |
WO 2005-053773 | Jun 2005 | WO |
WO 2007-078447 | Jul 2007 | WO |
Entry |
---|
Wiklof, Chris, “Display Technology Spawns Laser Camera,” LaserFocusWorld, Dec. 1, 2004, vol. 40, Issue 12, PennWell Corp., USA. |
Nikbin, Darius, “IPMS Targets Colour Laser Projectors,” Optics & Laser Europe, Mar. 1006, Isue 137, p. 11. |
Http://sciencegeekgirl.wordpress.com/category/science-myths/page/2/ Myth 7: Blood is Blue. |
Http://www.exploratorium.edu/sports/hnds_up/hands6.html “Hands Up! To Do & Notice: Getting the Feel of Your Hand”. |
Http://www.wikihow.com/See-Blook-Veins-in-Your-Hand-With-a- Flashlight “How to See Blood Veins in Your Hand With a Flashlight”. |
Number | Date | Country | |
---|---|---|---|
20210059599 A1 | Mar 2021 | US |
Number | Date | Country | |
---|---|---|---|
60817623 | Jun 2006 | US | |
60757704 | Jan 2006 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14249462 | Apr 2014 | US |
Child | 17027972 | US | |
Parent | 13444940 | Apr 2012 | US |
Child | 14249462 | US | |
Parent | 11985343 | Nov 2007 | US |
Child | 13444940 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11700729 | Jan 2007 | US |
Child | 11985343 | US | |
Parent | 11478322 | Jun 2006 | US |
Child | 11700729 | US |